Tel Aviv, Israel and Vancouver, British Columbia--(Newsfile Corp. - September 28, 2023) - Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) (FSE: CWY) ("Clearmind" or the "company"), a biotech company...
Will host a virtual investor conference titled “Psychedelics for Obesity” on Monday, June 12th, at 10:00 ...
Announced an agreement with IMP Clinical Supply Services. IMP will be responsible for the global clinical ...
Announces the filing of a patent application seeking to protect its unique combination of MEAI and SciSparc's ...
Dr. John H. Krystal, world-leading expert in alcoholism and depression, will serve on scientific advisory board VANCOUVER, June 21, 2022 (GLOBE...
VANCOUVER, June 15, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the "Company"), a biotech...
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and are...
SciSparc and Clearmind recently announced the filing of a patent application related to treating cocaine addiction...
The dedicated treatment demonstrated a significant decrease in preference for an area associated with cocaine VANCOUVER, June 07,...
No dedicated treatment currently available for cocaine addiction TEL AVIV, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a...